A Study of S-892216 in Participants With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

September 22, 2025

Study Completion Date

September 22, 2025

Conditions
COVID-19
Interventions
DRUG

S-892216

S-892216 will be administered orally as a tablet.

DRUG

Placebo

Placebo will be administered orally as a tablet.

Trial Locations (57)

23226

Clinical Research Partners LLC, Richmond

26537

Frontier Clinical Research LLC, Kingwood

30046

Balanced Life Health Care Solutions, Lawrenceville

32807

Combined Research Orlando Phase I-IV LLC, Orlando

33014

Palm Springs Community Health Center, Miami Lakes

33016

Quality Research of South Florida, Miami Lakes

33073

Invictus Clinical Research Group LLC, Coconut Creek

33126

LCC Medical Research, Miami

33133

CCM Clinical Research Group, Miami

33134

Hope Clinical Trials, Coral Gables

33135

Global Health Clinical Trials, Miami

33144

Continental Clinical Research, Miami

Oceane7 Medical & Research Center, Inc., Miami Lakes

33176

Entrust Clinical Research, Miami

33185

Kendall South Medical Center Inc, Miami

33705

Global Clinical Professionals, St. Petersburg

34142

Advanced Research for Health Improvement LLC, Immokalee

71913

Healthstar Research, Hot Springs

75126

Care United Research, LLC, Forney

75209

Alina Clinical Trials LLC, Dallas

78520

PanAmerican Clincal Research, Brownsville

Unknown

Japanese Site 10, Multiple Locations

Japanese Site 11, Multiple Locations

Japanese Site 12, Multiple Locations

Japanese Site 13, Multiple Locations

Japanese Site 14, Multiple Locations

Japanese Site 15, Multiple Locations

Japanese Site 16, Multiple Locations

Japanese Site 17, Multiple Locations

Japanese Site 18, Multiple Locations

Japanese Site 19, Multiple Locations

Japanese Site 1, Multiple Locations

Japanese Site 20, Multiple Locations

Japanese Site 21, Multiple Locations

Japanese Site 22, Multiple Locations

Japanese Site 23, Multiple Locations

Japanese Site 24, Multiple Locations

Japanese Site 25, Multiple Locations

Japanese Site 26, Multiple Locations

Japanese Site 27, Multiple Locations

Japanese Site 28, Multiple Locations

Japanese Site 29, Multiple Locations

Japanese Site 2, Multiple Locations

Japanese Site 30, Multiple Locations

Japanese Site 31, Multiple Locations

Japanese Site 32, Multiple Locations

Japanese Site 33, Multiple Locations

Japanese Site 34, Multiple Locations

Japanese Site 35, Multiple Locations

Japanese Site 36, Multiple Locations

Japanese Site 3, Multiple Locations

Japanese Site 4, Multiple Locations

Japanese Site 5, Multiple Locations

Japanese Site 6, Multiple Locations

Japanese Site 7, Multiple Locations

Japanese Site 8, Multiple Locations

Japanese Site 9, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shionogi

INDUSTRY